We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PLX market cap is 197.4M. The company's latest EPS is USD 0.2 and P/E is 12.32.
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 10.11M | 15.66M | 17.85M | 9.12M | 33.75M |
| Operating Income | -4.15M | 1.17M | 2.13M | -4.66M | 21.15M |
| Net Income | -3.62M | 164k | 2.36M | -5.5M | 18.32M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 38.35M | 47.64M | 65.49M | 53.4M | 52.74M |
| Operating Income | -20.46M | -13.01M | 10.46M | 3.92M | -5.5M |
| Net Income | -27.58M | -14.93M | 8.31M | 2.93M | -6.6M |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 73.89M | 78.49M | 82.26M | 82.35M | 102.34M |
| Total Liabilities | 28.68M | 28.58M | 29.36M | 34.12M | 35.11M |
| Total Equity | 45.21M | 49.9M | 52.91M | 48.23M | 67.23M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 73.67M | 55.79M | 84.43M | 73.42M | 82.35M |
| Total Liabilities | 79.7M | 66.43M | 50.87M | 30.21M | 34.12M |
| Total Equity | -6.04M | -10.64M | 33.57M | 43.21M | 48.23M |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.06M | -5.23M | -3.73M | 2.03M | 22.03M |
| Investing | -312k | -438k | -504k | -1.11M | 4.22M |
| Financing | 5.08M | 4.1M | N/A | 146k | 150k |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.29M | -25M | -1.32M | 8.67M | -11.99M |
| Investing | 18.92M | -5.04M | -16.71M | 4.22M | -2.37M |
| Financing | 12.08M | 8.24M | 24.67M | -16.79M | 9.33M |
| Market Cap | 197.401M |
| Price to Earnings Ratio | 12.32 |
| Price to Sales Ratio | 2.51 |
| Price to Cash Ratio | 0.51 |
| Price to Book Ratio | 2.85 |
| Dividend Yield (LTM) | N/A |
| Shares Outstanding | 80.57M |
| Average Volume (1 week) | 526.16k |
| Average Volume (1 Month) | 677.12k |
| 52 Week Change | 62.25% |
| 52 Week High | 3.19 |
| 52 Week Low | 1.36 |
| Spread (Intraday) | 0.47 (18.8%) |
| Company Name | Protalix BioTherapeutics Inc |
| Address |
2 University Plaza Hackensack, New Jersey 07601 |
| Website | https://www.protalix.com |
| Industry | Biotechnology & Life Sciences |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Register with Email
Already have an account? Sign in
Don't have an account? Sign up
By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.
Hot Features
Premium
